NASS 2019 Annual Meeting

Cerapedics, Inc. 

Booth 4618

Westminster, CO  
      United States





Cerapedics is an advanced orthobiologics company focused on developing its proprietary biomimetic small peptide molecule (P-15) for commercialization in spinal applications. i-FACTOR® Peptide Enhanced Bone Graft (P-15/ABM) is only the second FDA PMA Approved bone graft on the market, and it has shown statistical superiority to local autograft through an IDE trial on single-level ACDFs in overall clinical success at one year. i-FACTOR® is the only biologic bone graft in orthopedics that incorporates a small peptide as an attachment factor to stimulate the natural bone healing process. This novel mechanism of action (Attract, Attach, Activate) is designed to support safer and more predictable bone formation compared to other commercially available bone growth factors.



Product Categories

Biomaterials
- Bone Graft Matrix
- Peptide Enhanced Bone Graft

Fusion
- Anterior Cervical Discectomy and Fusion (ACDF)
- Spine Fusion

Implants
- Biomaterials

Spine Biologics
- Peptide Enhanced Bone Graft